Characteristics | N = 17 |
---|---|
Male,n(%) | 11 (64.7) |
Age at trasplant, years. Median (IQR) | 14.3 (10.8–17.2) |
Time between diagnosis and transplant, years. Median (IQR) | 5.8 (3.9–7.4) |
Donant type, n(%) | |
Live donor | 10 (58.8) |
Deceased donor | 7 (41.2) |
Antropometrical measurements, | |
Weight [Kg], median (IQR) | 34 (26–48) |
Weight z-score, mean (±SD) | −1.1 (1.2) |
Height [cm], median (IQR) | 150 (124–155) |
Height z-score, mean (±SD) | −1.8 (0.9) |
BMI [Kg/m2], median (IQR) | 18.3 (15.2–19.3) |
BMI z-score, mean (±SD) | −0.7 (1.1) |
Previous nephrectomy,n(%) | 10 (58.8) |
Pre-transplant Plasmapheresis,n(%) | 8 (47.1) |
Pre-transplant dialysis modality,n(%) | |
Hemodialysis | 10 (58.8) |
Peritoneal dialysis, | 8 (47.1) |
Induction therapy,n(%) | |
Thymoglobulin | 5 (29.4) |
Basiliximab | 5 (29.4) |
Daclizumab | 7 (41.2) |
Patients Undergoing Plasmapheresis,n(%) | |
Plasmapheresis procedures, median (IQR) | 9 (6–11) |
Remission with therapy,n(%) | |
Live donor | 5/7 |
Deceased donor | 7/10 |
Acute Rejection,n(%) | 3 (17.7) |
Injert Lost,n(%) | 8 (35.3) |
Length of hospital stay (days), median (IQR) | 28 (19–46) |
Death,n(%) | 5 (29.4) |